AETC National Coordinating Resource Center

François-Xavier Bagnoud Center

Rutgers School of Nursing
65 Bergen Street, 8th floor
Newark, NJ 07101
United States

(973) 972-5141
(973) 972-0397

The AIDS Education and Training Center (AETC) National Coordinating Resource Center (NCRC) provides education, training, and capacity building resources for the AETC Program (8 regional centers, 2 national centers, the National HIV Curriculum, and special projects) to support the provision of timely, high quality, state-of-the-science information to healthcare professionals working with existing and emerging populations affected by HIV. The AETC NCRC functions within the AETC Program to provide:

  • National HIV training curricula
  • A virtual resource library
  • National AETC Program resource development
  • An AETC Program directory and event calendar
  • National AETC Program group coordination and collaboration
  • AETC Program marketing and communication services
  • Coordination and facilitation of the annual Ryan White HIV/AIDS Program Clinical Conference 
Principal Investigator
Phone: (973) 972-5141
Fax: (973) 972-0397
Program Director
Phone: (973) 972-6268
Fax: (973) 972-4263
Marketing Coordinator
Phone: (973) 972-5528

Resources: 49

Title Sort ascending Publish Date Review Date
Using Trauma-Informed Dental Care for People with HIV Infographic
U.S. Monkeypox (MPX) - Information and Recommendations
Tips for Managing Digital Design Projects
Stock Photo Library
Stock Image Website and Resource List
Self-care, Resiliency, and Stress Management for Healthcare Providers
Ryan White HIV/AIDS Program (RWHAP) Clinical Conference
Risk, Presentation, Treatment, and Outcomes of COVID-19 in People with HIV
Results and Response to a 10-State COVID-19 Practice Impact Survey in the Mountain West Region
Resources for HRSA HAB Performance Measures
Resources for Accessibility
Reaching People with HIV in Rural United States
Rapid (Immediate) ART Initiation & Restart: Guide for Clinicians
Quick Guide: CDC HIV Laboratory Testing Recommendations
Prescribing PrEP: A Guide for Healthcare Providers
Post COVID Syndrome: An Overview and Approach to Management
Passport to Cure
Non-Occupational Post-Exposure Prophylaxis (nPEP) Toolkit
New Pandemic, Old Inequities: Impacts of COVID-19 and HIV on Marginalized Populations
Myths about Providing HCV Treatment to People with HIV with Substance Use Disorder(s)
Integrating Behavioral Health into Primary HIV Care — Covering the Bases
Increasing Viral Suppression among People with HIV with Mental Health Disorders Infographic
Implementing Substance Use Disorder (SUD) Services in HIV Care Settings Toolkit
HIV/HCV Co-infection: An AETC National Curriculum
HIV Health Outcomes: It’s More Than Just Viral Suppression
HIV Epidemic Rapid Response Toolkit
HIV Care Conversations
HIV Care Continuum: Key Resources for HIV Clinicians
HIV & SARS-CoV-2 Webinar Series
HHS Adult ART Guidelines: Treatment-Experienced Patients
HHS Adult ART Guidelines: Transgender People with HIV
HHS Adult ART Guidelines: Initial Therapy
HHS Adult ART Guidelines: HIV and ART in Older People
Hepatitis C: Getting Cured Is Easier than Ever
Hep C Free Postcard
Flyer: Hepatitis C Screening and Treatment in People with HIV
Federal Training Centers Collaborative (FTCC) Virtual Learning Session Materials
Federal COVID-19 Resources
Evaluating AETC NCRC Partnerships for Impact
Direct-acting Antiviral (DAA) Prior Authorization Letter Templates
COVID-19, HIV, and Housing Instability
Conducting a Primary or Acute Care HIV Telemedicine Visit
Community Health Worker Training Resources
Clinician Mobile Apps for HIV-related Care
Brand and Generic Names of ARVs in the United States and Mexico
Best Practices for Finding and Crediting Images
Barriers to Curing Hepatitis C Virus among Coinfected People with HIV Infographic
Assisting HIV Patients Returning to Mexico and Central America / Asistiendo a los Pacientes que Regresan a México y Centroamérica
AETC Program Interprofessional Education (IPE) Toolkit

Articles: 39

Title Sort ascending Publish date Review date
Use of Dolutegravir in Dialysis
Updates on Mpox: Vaccination Efficacy and Spectrum of Disease in People with HIV
Updates in Antiretroviral Treatment during Pregnancy: Dolutegravir in Late Pregnancy
Updated CDC PrEP Guidelines
Tissue Levels of TAF: Too Low for PrEP?
Tenofovir Alafenamide (TAF) and Darunavir/Cobicistat in Pregnant Women
Switching from TDF/FTC to TAF/FTC
START-ing TEMPRANO: Early Initiation of Antiretroviral Therapy for HIV
Safety of Dolutegravir at Conception: Updated Data
Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)
Rapid ART Start
PrEP: Bone Density Improves after Stopping TDF/FTC
New ARV Approval - Fostemsavir
Naltrexone Improves Virologic Suppression
Long-acting Injectable PrEP: Cabotegravir
Long-acting Injectable PrEP Approved: Cabotegravir
Long-Acting Injectable ART: Cabotegravir + Rilpivirine
Immediate ART Initiation Improves Time to Viral Suppression
Ibalizumab Approved for Persons with Multidrug Resistant HIV
HIV-related Journal Articles from AETC-Affiliated Researchers and Faculty, 2022
HIV Meds Updates: Long-acting Injectable Therapy: Lenacapavir
HIV Meds Updates - TANGO and SALSA Studies: Switch to DTG/3TC from 3-Drug ART
HIV Meds Updates - Long-acting Injectable Therapy: Cabotegravir + Rilpivirine
HIV Meds Update: FDA Approves Lenacapavir, New Long-Acting Injectable ARV
HIV Meds Update: DoxyPEP – Doxycycline for STI Prevention
HIV Meds Update: ART in Acute HIV--Decreasing HIV DNA
HIV Meds Update: Anal Dysplasia Treatment Prevents Anal Cancer - The ANCHOR Study
HIV Meds Update - RAPID: Immediate ART Initiation
HIV Care Tools – A New Resource for Ending the HIV Epidemic
FDA Approves 2-Drug Combination of Dolutegravir + Lamivudine
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy
Dolutegravir in Early Pregnancy: Updates on Possible Risk of Neural Tube Defects
Dolutegravir + 3TC in Initial Therapy
Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study
Darunavir/Cobicistat/FTC/TAF Coformulation Approved; More Data from EMERALD Switch Study
Bictegravir/TAF/FTC in Women
Bictegravir Approved for Initial ART, in Combination with TAF/FTC
AETC Representation at the 2022 National Ryan White Conference on HIV Care & Treatment
Day Title
12/03 to 12/05 2023 Ryan White HIV/AIDS Program (RWHAP) CLINICAL CONFERENCE (National, Oregon)
Sunday, December 3, 2023 (All day) to Tuesday, December 5, 2023 (All day)
Event type: Conferences & Events